Future cardiovascular disease treatment will involve more remote monitoring, says GlobalData

Much of the global market for pacemakers alone – noted by leading data and analytics company GlobalData to be valued at just under $3bn in 2020 – could be overtaken by devices that add remote capabilities.

Ashley Young, Senior Medical Devices Analyst at GlobalData, comments: “Beyond cardiac rhythm management, the potential for remote monitoring in cardiovascular treatment is limitless. There is plenty of market share up for the taking for devices offering remote monitoring features.”

Medtronic is an example of a company that has made significant strides in this area, with remote-monitoring functions built into some of its cardiac rhythm monitoring devices, including implantable cardioverter defibrillators (ICDs) and pacemakers. Using the remote functionalities built into these devices,...